Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
about
A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients.Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.
P2860
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Analysis of the cardiovascular ...... er 50% cyclosporine reduction.
@en
Analysis of the cardiovascular ...... er 50% cyclosporine reduction.
@nl
type
label
Analysis of the cardiovascular ...... er 50% cyclosporine reduction.
@en
Analysis of the cardiovascular ...... er 50% cyclosporine reduction.
@nl
prefLabel
Analysis of the cardiovascular ...... er 50% cyclosporine reduction.
@en
Analysis of the cardiovascular ...... er 50% cyclosporine reduction.
@nl
P2093
P2860
P1476
Analysis of the cardiovascular ...... er 50% cyclosporine reduction.
@en
P2093
A Benedict Cosimi
Francesca Cardarelli
Francis L Delmonico
Manuel Pascual
Mary Lin Farrell
Nina Tolkoff-Rubin
Susan L Saidman
Vivian Shih
Waichi Wong
Wolfgang C Winkelmayer
P2860
P304
P356
10.1111/J.1399-0012.2004.00171.X
P577
2004-08-01T00:00:00Z